Organization | Dhaka Medical College

Dhaka Medical College Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Dhaka Bangladesh (1946)

Organization Overview

First Clinical Trial

2012

NCT01613729

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Dhaka Hospital | Dhaka Medical College | Indoor Medical Officer, Department of ENT & Head-Neck Surgery, Dhaka Medical College Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

rosuvastatin (crestor) (1 trial)

Drugs in Phase 3 Trials (4)

baricitinib (olumiant) (1 trial)

doxycycline (vibramycin) (1 trial)

ivermectin (stromectol) (1 trial)

polyvinyl pyrrolidone (1 trial)

Drugs in Phase 2 Trials (3)

allogeneic adipose derived mesenchymal stem cell (1 trial)

COVID-19 convalescent plasma (1 trial)

povidone-iodine (1 trial)

Drugs in Other Trials (6)

albendazole (Albenza) (1 trial)

amoxicillin (1 trial)

colchicine (colbenemid) (1 trial)

cow milk (1 trial)

pyrequan (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Convalescence (Phase 2)

Dyslipidemias (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial APIs: 14